SCHEMBL2115401

SCHEMBL2115401

Cc1cccc(-c2nc3c(cnn3-c3ccccc3)c(=O)n2-c2ccccc2)c1

nearest known ligand 0.93

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TP53 P04637 4/20 0.93
MAPT P10636 3/20 0.93
THRB P10828 1/20 0.85
PTGS2 P35354 1/20 0.61
ALDH1A1 P00352 3/20 0.61
DPP4 P27487 3/20 0.61
TSHR P16473 3/20 0.61
HTT P42858 3/20 0.61
LMNA P02545 3/20 0.61
HPGD P15428 2/20 0.61
ALOX15 P16050 1/20 0.61
MAPK1 P28482 1/20 0.61
GRM1 Q13255 4/20 0.60
SMN1; SMN2 Q16637 4/20 0.60
GRM5 P41594 1/20 0.59
KDM4E B2RXH2 1/20 0.57
KMT2A Q03164 1/20 0.57
POLB P06746 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2116120 0.96 TP53 (1.00) TP53MAPTTHRBPTGS2ALDH1A1
SCHEMBL2117983 0.96 THRB (0.87) TP53MAPTTHRBPTGS2ALDH1A1
SCHEMBL2117476 0.94 TP53 (0.83) TP53MAPTTHRBPTGS2ALDH1A1
SCHEMBL2115647 0.94 THRB (0.83) TP53MAPTTHRBPTGS2ALDH1A1
SCHEMBL2120329 0.93 MAPT (1.00) TP53MAPTTHRBALDH1A1TSHR
SCHEMBL2116983 0.93 TP53 (0.86) TP53MAPTTHRBPTGS2ALDH1A1
SCHEMBL1753275 0.93 TP53 (0.86) TP53MAPTTHRBPTGS2ALDH1A1
SCHEMBL2117907 0.92 THRB (1.00) TP53MAPTTHRBALDH1A1DPP4
SCHEMBL2119540 0.92 TP53 (0.82) TP53MAPTTHRBPTGS2ALDH1A1
SCHEMBL2114882 0.90 MAPT (0.76) TP53MAPTTHRBPTGS2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8158634-B2 Compounds and compositions as inhibitors of cannabinoid receptor 1 activity IRM LLC (BM) 2012-04-17 US claimed
US-20120225869-A1 COMPOUNDS AND COMPOSITIONS AS INHIBITORS OF CANNABINOID RECEPTOR 1 ACTIVITY IRM LLC (BM) 2012-09-06 US disclosed
US-8158634-B2 Compounds and compositions as inhibitors of cannabinoid receptor 1 activity IRM LLC (BM) 2012-04-17 US disclosed
US-20090247517-A1 COMPOUNDS AND COMPOSITIONS AS INHIBITORS OF CANNABINOID RECEPTOR 1 ACTIVITY IRM LLC (BM) 2009-10-01 US disclosed
US-20070299047-A1 Combination of Organic Compounds MAHER WILLIAM 2007-12-27 US disclosed
EP-1807429-A2 COMPOUNDS AND COMPOSITIONS AS INHIBITORS OF CANNABINOID RECEPTOR 1 ACTIVITY IRM, LLC (BM) 2007-07-18 EP disclosed
WO-2006047516-A2 COMPOUNDS AND COMPOSITIONS AS INHIBITORS OF CANNABINOID RECEPTOR 1 ACTIVITY IRM LLC (BM) 2006-05-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070299047-A1 Combination of Organic Compounds GLP1R, PPARG, GCGR TP53 4351/4885MAPT 4328/4885THRB 427/4885
US-20120225869-A1 COMPOUNDS AND COMPOSITIONS AS INHIBITORS OF CANNABINOID RECEPTOR 1 ACTIVITY CNR1, CNR2, FAAH TP53 4640/4885MAPT 1780/4885THRB 1943/4885
US-20090247517-A1 COMPOUNDS AND COMPOSITIONS AS INHIBITORS OF CANNABINOID RECEPTOR 1 ACTIVITY CNR1, CNR2, FAAH TP53 4640/4885MAPT 1780/4885THRB 1943/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.